American journal of physiology. Renal physiology · 2026
Abnormal activation of the mineralocorticoid receptor in the aldosterone-sensitive distal nephron contributes to fructose-induced salt-sensitive hypertension.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Ronghao, Kim Najeong, Shi Shujie, Jadhav Darshan Aatmaram, Brostek Autumn, Forester Beau R, Shukla Rashi, Qu Christina, Kramer Benjamin K, Moss Fraser J, Garvin Jeffrey L, Kleyman Thomas R, Gonzalez-Vicente Agustin
Аннотация
Fructose high-salt (FHS) diets increase blood pressure (BP). The mineralocorticoid receptor (MR) regulates Na+ reabsorption by the aldosterone-sensitive distal nephron (ASDN). The MR can be transactivated by glucocorticoids, including those locally produced by hydroxysteroid 11-beta dehydrogenase 1 (11β-HSD1). The epithelial sodium channel (ENaC) is a key transporter regulated by the MR. We hypothesized that fructose-induced salt-sensitive hypertension depends, in part, on abnormal activation of MRs in the ASDN, with consequent increases in ENaC expression. We found that aldosterone-upregulated genes in mice ASDN significantly overlapped with 74 genes upregulated by FHS in the rat kidney cortex (13/74; P ≤ 1 × 10-8), and that these 74 genes are prominently expressed in rat ASDN cells. In addition, the average z-score expression of mice aldosterone-upregulated genes is highly correlated with FHS compared with glucose high-salt (GHS) in the rat kidney cortex (Pearson correlation: r = 0.75, P ≤ 0.005). FHS and GHS suppressed serum aldosterone to similar levels; however, 11β-HSD1/11β-HSD2 ratio in the kidney cortex at both transcripts (Δ32 ± 13%; P ≤ 0.03; n = 6) and protein levels (Δ61 ± 27%; P ≤ 0.05; n = 6) was increased in FHS. FHS also increased BP by 23 ± 6 mmHg compared with GHS, and blocking MRs with eplerenone prevented this increase. In addition, inhibiting ENaC with amiloride significantly reduced BP in FHS from 148 ± 6 to 134 ± 5 mmHg (P ≤ 0.019). Compared with GHS, FHS increased total and cleaved αENaC protein by 89 ± 14% (P ≤ 0.03) and 47 ± 16% (P ≤ 0.01), respectively. FHS did not change β- or γ-subunit expression. These results suggest that fructose-induced salt-sensitive hypertension depends, in part, on abnormal Na+ retention by ENaC, resulting from the activation of MRs by glucocorticoids.NEW & NOTEWORTHY This study identifies abnormal mineralocorticoid receptor (MR) activation as a driver of fructose-induced salt-sensitive hypertension. Despite unchanged serum aldosterone levels, increased renal 11β-HSD1 suggests MR activation by glucocorticoids. The blood pressure increase caused by fructose and salt was reversed by MR blockade with eplerenone and ENaC inhibition with amiloride. These findings reveal a novel mechanism linking fructose consumption to abnormal distal nephron regulation, providing new insights into the pathogenesis of diet-induced hypertension.